CURADEL
LIVE

Serial Number

86716408

Owner

Curadel, LLC

Attorney

Susan B. Meyer

First Use Date

Jan 1, 2013

Filing Date

Aug 6, 2015

Add to watchlist:

No watchlists yet
View on USPTO

CURADEL Trademark

Serial Number: 86716408 • Registration: 5281759

CURADEL is a trademark filed by Curadel, LLC on August 6, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Curadel, LLC (15 trademarks)

Natick, MA 01760

Entity Type: 16

Trademark Details

Filing Date

August 6, 2015

Registration Date

September 5, 2017

First Use Anywhere

January 1, 2013

First Use in Commerce

September 1, 2016

Published for Opposition

February 9, 2016

Goods & Services

Providing consumer information in the field of cancer treatment and diagnosis via the Internet and social media

Medical and scientific research services in the field of cancer treatment and diagnosis

Medical and surgical equipment for use in surgical procedures, namely, cameras and near-infrared cameras, and operating software used therewith, all sold as a unit; medical and surgical equipment for use in medical procedures, namely, cameras and near-infrared cameras; medical and surgical equipment for use in medical imaging and visualization, namely, cameras and near-infrared cameras, and operating software used therewith, all sold as a unit, medical and surgical equipment for use in medical imaging and visualization, namely, visual wavelength imaging cameras, ultraviolet wavelength imaging cameras, radioscintigraphic detection hardware, optical lenses, image detectors, light sources, monitors, and operating software used therewith, all sold as a unit; medical and surgical equipment for use in medical imaging and visualization, namely, cameras and near-infrared cameras; medical and surgical equipment for use in real-time surgical imaging and visualization, namely, cameras and near-infrared cameras, and operating software used therewith, all sold as a unit; medical and surgical equipment for use in real-time surgical imaging and visualization, namely, cameras and near-infrared cameras; medical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; surgical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; real-time medical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; real-time surgical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; oncological imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; real-time oncological imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit

Contrast agents for use in surgical and medical imaging and visualization; fluorescent contrast agents for use in surgical and medical imaging and visualization; exogenous contrast agents for use in surgical and medical imaging and visualization; near-infrared contrast agents for use in surgical and medical imaging and visualization; exogenous near-infrared contrast agents for use in surgical and medical imaging and visualization; near-infrared contrast agents for use in surgical procedures; exogenous near-infrared contrast agents for use in surgical procedures; near-infrared contrast agents for use in medical imaging and visualization; exogenous near-infrared contrast agents for use in medical imaging and visualization; near-infrared contrast agents for use in real-time surgical imaging and visualization; exogenous near-infrared contrast agents for use in real-time surgical imaging and visualization, none of the foregoing being ophthalmic preparations, otorhinolaryngological preparations, or preparations for the treatment of inflammation; * none of the foregoing are for use in connection with wound management, medical dressing materials, haemostats, sealants, and blood clotting agents *

Providing health information in the field of cancer treatment and diagnosis via the Internet and social media

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Mar 17, 2026 NURC
AMENDMENT UNDER SECTION 7 - PROCESSED
Feb 26, 2026 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 7 REQUEST RECEIVED
Nov 17, 2025 ES7R
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 20, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 20, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 20, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 6, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 5, 2022 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 19, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 19, 2021 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 18, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 18, 2019 COAR
REGISTERED-PRINCIPAL REGISTER
Sep 5, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 2, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 1, 2017 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2017 CRFA
ASSIGNED TO LIE
Jul 31, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 14, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 14, 2017 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 14, 2017 CNRT
ASSIGNED TO EXAMINER
Jun 14, 2017 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 18, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 18, 2017 COAR
ASSIGNED TO EXAMINER
Oct 25, 2016 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Oct 21, 2016 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 20, 2016 AITU
USE AMENDMENT FILED
Oct 5, 2016 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 5, 2016 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 5, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 9, 2016 NPUB
PUBLISHED FOR OPPOSITION
Feb 9, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 20, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 4, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 25, 2015 XAEC
ASSIGNED TO LIE
Nov 25, 2015 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 25, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 25, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 25, 2015 CNEA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 24, 2015 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 24, 2015 PARI
ASSIGNED TO EXAMINER
Nov 18, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2015 NWOS